Genetic testing that allows people to learn which health disorders they are more vulnerable to developing provides information they find valuable and can act on. This type of testing has become widely available in recent years, partially due to the work of Jim Plante.
Mr. Plante founded Pathway Genomics in 2008 and continued as the company’s Chief Executive Officer until September 2017. Currently, he is the CEO of another company he founded. Klotho Therapeutics concentrates on developing effective treatments for major diseases, particularly kidney disease.
Consider what happens when someone decides to find out whether genetic testing indicates he or she is more likely to become hypertensive or develop high cholesterol. These individuals may have parents with high blood pressure or high cholesterol, making them suspect they will be prone to the disorders as well.
Taking Preventive Action
Confirming this with the test motivates them to take preventive action and keep a careful watch on the situation. They might buy a blood pressure monitor to use at home and have their cholesterol checked annually. They can make changes in their diet to help them lose weight if necessary. Beginning a regular exercise program is another preventive strategy …